Skip to content

Validation of Software for Assessment of Atrial Fibrillation From PPG Data Acquired by a Wearable Smartwatch

Fitbit Atrial Fibrillation From PPG Data Validation Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04380415
Enrollment
450000
Registered
2020-05-08
Start date
2020-05-06
Completion date
2021-03-08
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

Validate the Fitbit PPG RhythmDetect Software System algorithm for providing notifications by identifying rhythms suggestive of atrial fibrillation or atrial flutter events.

Interventions

DIAGNOSTIC_TESTSingle lead ambulatory ECG patch

Single lead ambulatory ECG patch worn on the chest

Sponsors

Fitbit LLC
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults 22 years of age or older * Capable of giving informed consent * U.S. resident * No prior history of atrial fibrillation or atrial flutter * Fitbit account, with one of the following devices paired: * Ionic, Versa, Versa Lite, Versa 2, Versa 3, Charge 3, Charge 4, Inspire HR, Inspire 2, or Sense updated to the latest available firmware.

Exclusion criteria

* Diagnosis or history of Atrial Fibrillation at time of consent * Diagnosis or history of Atrial Flutter at time of consent * Current use of anticoagulation medication * Cardiac pacemaker or implantable cardioverter-defibrillator

Design outcomes

Primary

MeasureTime frameDescription
Simultaneous measurement of AF ≥ 30 seconds with detection7 daysSimultaneous measurement of AF ≥ 30 seconds on ECG patch monitor during any of the pulse tachograms that generate the first Irregular Heart Rhythm Detection during ECG monitoring.

Secondary

MeasureTime frameDescription
Simultaneous measurement of AF ≥ 30 seconds with pulse tachograms7 daysSimultaneous measurement of AF ≥ 30 seconds on the ECG patch monitor during each of the pulse tachograms that contributed to the first Irregular Heart Rhythm Detection, among those detections confirmed by ECG.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026